Small Cap Wonder

From MicroCap Watch | Ad

Read why this microcap stock might stand out in the market.

Get the info now.

PRAX Insider Trading (Praxis Precision Medicines)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.80%

Insider Buying (Last 12 Months): $250,971.86

Insider Selling (Last 12 Months): $8,513,858.62

Praxis Precision Medicines Insider Trading History Chart

Praxis Precision Medicines Share Price & Price History

^$20.44

▲ +0.66 (3.34%)

As of 10/20/2021 01:00 AM ET

Days: 30 | 90 | 365

Seattle Cannabis Blockbuster Set to Double Sales in Next 2 Years!

From All Marijuana Stocks | Ad

Thanks to a recent reorganization, acquisitions and strategic partnerships, one Seattle cannabis blockbuster is poised for a massive expansion in the coming 24 months. With plans to double its annual sales in the next two years, this company's shares could potentially skyrocket in value.

Get all the details on this potential penny stock

Praxis Precision Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/5/2021	Parallel Master Fund L.P. Bsof	Major Shareholder	Sell	23,946	$19.15	$458,565.90
10/1/2021	Parallel Master Fund L.P. Bsof	Major Shareholder	Sell	22,600	$19.13	$432,338.00
8/23/2021	Parallel Master Fund L.P. Bsof	Major Shareholder	Sell	352,396	$19.00	$6,695,524.00
8/18/2021	Marcio Souza	CEO	Buy	9,542	$15.79	$150,668.18
8/18/2021	Parallel Master Fund L.P. Bsof	Major Shareholder	Sell	3,000	$15.88	$47,640.00
8/2/2021	Parallel Master Fund L.P. Bsof	Major Shareholder	Sell	40,000	$15.78	$631,200.00
7/30/2021	Parallel Master Fund L.P. Bsof	Major Shareholder	Sell	15,854	$15.68	$248,590.72
11/10/2020	Marcio Souza	CEO	Buy	3,846	$26.08	$100,303.68	24,450

Insider Trading at Praxis Precision Medicines?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Praxis Precision Medicines and related companies.

SEC Filings (Institutional Ownership Changes) for Praxis Precision Medicines (NASDAQ:PRAX)

92.10% of Praxis Precision Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Praxis Precision Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/27/2021	Endurant Capital Management LP	199,565	$3.65M	1.0%	N/A	0.446%
8/25/2021	Marshall Wace LLP	188,836	$3.45M	0.0%	N/A	0.422%
8/25/2021	Marshall Wace North America L.P.	139,897	$2.56M	0.0%	-56.0%	0.313%
8/23/2021	Morgan Stanley	100,017	$1.83M	0.0%	+2,168.5%	0.224%
8/19/2021	Bradley Foster & Sargent Inc. CT	11,000	$0.20M	0.0%	+57.1%	0.028%
8/17/2021	Woodline Partners LP	356,440	$6.52M	0.1%	+41.6%	0.922%
8/17/2021	Sphera Funds Management LTD.	75,600	$1.38M	0.1%	N/A	0.196%
8/17/2021	Metropolitan Life Insurance Co NY	8,298	$0.15M	0.0%	+207,350.0%	0.021%
8/17/2021	Millennium Management LLC	61,314	$1.12M	0.0%	+138.7%	0.159%
8/17/2021	MetLife Investment Management LLC	10,839	$0.20M	0.0%	+108.6%	0.028%
8/17/2021	PFM Health Sciences LP	455,374	$8.32M	0.3%	N/A	1.178%
8/17/2021	Citadel Advisors LLC	1,858,913	$33.98M	0.0%	+16.0%	4.808%
8/16/2021	Squarepoint Ops LLC	17,427	$0.32M	0.0%	N/A	0.045%
8/16/2021	Bank of America Corp DE	14,271	$0.26M	0.0%	+14.5%	0.037%
8/16/2021	Point72 Asset Management L.P.	786,995	$14.39M	0.1%	+474.5%	2.035%
8/16/2021	Cubist Systematic Strategies LLC	47,797	$0.87M	0.0%	+1,400.7%	0.124%
8/16/2021	Blackstone Inc	5,801,487	$106.05M	0.2%	-31.8%	15.004%
8/16/2021	California State Teachers Retirement System	33,632	$0.62M	0.0%	+102.2%	0.087%
8/16/2021	Alyeska Investment Group L.P.	75,000	$1.37M	0.0%	N/A	0.194%
8/16/2021	Royal Bank of Canada	1,673	$31K	0.0%	+93.6%	0.004%
8/16/2021	Morgan Stanley	100,017	$1.83M	0.0%	+2,168.5%	0.259%
8/16/2021	Credit Suisse AG	10,826	$0.20M	0.0%	N/A	0.028%
8/16/2021	Charles Schwab Investment Management Inc.	119,719	$2.19M	0.0%	+64.8%	0.310%
8/16/2021	State Street Corp	351,313	$6.42M	0.0%	-51.9%	0.909%
8/16/2021	Kingdon Capital Management L.L.C.	250,000	$4.57M	0.5%	N/A	0.647%
8/16/2021	Nuveen Asset Management LLC	120,004	$2.19M	0.0%	+112.2%	0.310%
8/16/2021	Avoro Capital Advisors LLC	1,600,000	$29.25M	0.5%	+0.2%	4.138%
8/16/2021	Goldman Sachs Group Inc.	86,386	$1.58M	0.0%	-13.3%	0.223%
8/16/2021	Marshall Wace LLP	188,836	$3.45M	0.0%	N/A	0.488%
8/13/2021	Renaissance Technologies LLC	37,400	$0.68M	0.0%	N/A	0.097%
8/13/2021	Northern Trust Corp	223,186	$4.08M	0.0%	+84.9%	0.577%
8/13/2021	Laurion Capital Management LP	493,658	$9.02M	0.1%	+887.3%	1.277%
8/13/2021	Franklin Resources Inc.	274,806	$5.02M	0.0%	+9.9%	0.711%
8/13/2021	Geode Capital Management LLC	344,017	$6.29M	0.0%	+63.7%	0.890%
8/13/2021	Vanguard Group Inc.	2,547,753	$46.57M	0.0%	+150.9%	6.589%
8/13/2021	FMR LLC	4,702,929	$85.97M	0.0%	+9.6%	12.163%
8/12/2021	CNA Financial Corp	14,831	$0.27M	0.1%	+49.3%	0.038%
8/12/2021	State of Wisconsin Investment Board	31,500	$0.58M	0.0%	N/A	0.081%
8/12/2021	Legal & General Group Plc	2,952	$54K	0.0%	+156.7%	0.008%
8/12/2021	JPMorgan Chase & Co.	16,400	$0.30M	0.0%	+120.0%	0.042%
8/12/2021	The Manufacturers Life Insurance Company	14,543	$0.27M	0.0%	+128.7%	0.038%
8/12/2021	Monashee Investment Management LLC	100,000	$1.83M	0.2%	N/A	0.259%
8/11/2021	Bank of New York Mellon Corp	68,931	$1.26M	0.0%	+107.3%	0.178%
8/11/2021	BlackRock Inc.	1,513,973	$27.68M	0.0%	+25.3%	3.916%
8/11/2021	Deutsche Bank AG	16,964	$0.31M	0.0%	+126.0%	0.044%
8/10/2021	Virtus ETF Advisers LLC	10,801	$0.20M	0.1%	N/A	0.028%
8/10/2021	Citigroup Inc.	36,893	$0.67M	0.0%	-21.0%	0.095%
8/6/2021	Ameritas Investment Partners Inc.	1,912	$35K	0.0%	+106.9%	0.005%
8/6/2021	Swiss National Bank	48,000	$0.88M	0.0%	N/A	0.124%
8/5/2021	Rhumbline Advisers	29,070	$0.53M	0.0%	+174.5%	0.075%
8/5/2021	Los Angeles Capital Management LLC	17,600	$0.32M	0.0%	-4.5%	0.046%
8/2/2021	New York State Common Retirement Fund	20,989	$0.38M	0.0%	+99.9%	0.054%
8/2/2021	Alta Wealth Advisors LLC	31,028	$0.57M	0.4%	N/A	0.080%
7/30/2021	Alliancebernstein L.P.	1,419,368	$25.95M	0.0%	+59.2%	3.671%
5/21/2021	Citadel Advisors LLC	1,602,880	$52.51M	0.0%	+0.5%	4.146%
5/18/2021	Millennium Management LLC	25,689	$0.84M	0.0%	N/A	0.066%
5/18/2021	Point72 Asset Management L.P.	136,995	$4.49M	0.0%	-45.2%	0.354%
5/18/2021	Verition Fund Management LLC	474,456	$15.54M	0.2%	-17.4%	1.227%
5/18/2021	Morgan Stanley	4,409	$0.14M	0.0%	-69.2%	0.011%
5/18/2021	Citadel Advisors LLC	1,602,880	$52.51M	0.0%	+0.5%	4.146%
5/17/2021	Royal Bank of Canada	864	$28K	0.0%	+204.2%	0.002%
5/17/2021	Woodline Partners LP	251,663	$8.24M	0.2%	-16.7%	0.651%
5/17/2021	Janus Henderson Group PLC	1,063,389	$34.85M	0.0%	+18.5%	2.750%
5/17/2021	Acuta Capital Partners LLC	154,229	$5.05M	1.8%	+103.9%	0.399%
5/17/2021	Nuveen Asset Management LLC	56,565	$1.85M	0.0%	+39.3%	0.146%
5/17/2021	Goldman Sachs Group Inc.	99,669	$3.27M	0.0%	+51.6%	0.258%
5/13/2021	Bank of New York Mellon Corp	33,248	$1.09M	0.0%	+12.1%	0.086%
5/13/2021	Citigroup Inc.	46,687	$1.53M	0.0%	+2,032.8%	0.121%
5/12/2021	Northern Trust Corp	120,690	$3.95M	0.0%	-5.2%	0.312%
5/12/2021	Geode Capital Management LLC	210,158	$6.88M	0.0%	+2.5%	0.544%
5/12/2021	JPMorgan Chase & Co.	7,456	$0.24M	0.0%	+33.6%	0.019%
5/12/2021	E Fund Management Co. Ltd.	1,564	$51K	0.0%	N/A	0.004%
5/11/2021	New York State Common Retirement Fund	10,500	$0.34M	0.0%	+22.1%	0.027%
5/11/2021	Jennison Associates LLC	197,510	$6.47M	0.0%	-0.8%	0.511%
5/10/2021	Rafferty Asset Management LLC	37,594	$1.23M	0.0%	N/A	0.097%
5/7/2021	BlackRock Inc.	1,208,051	$39.58M	0.0%	+0.9%	3.127%
5/7/2021	Harvard Management Co. Inc.	778,517	$25.50M	1.4%	-1.8%	2.015%
5/6/2021	Rhumbline Advisers	10,589	$0.35M	0.0%	+5.0%	0.027%
5/6/2021	Alliancebernstein L.P.	891,553	$29.21M	0.0%	+28.1%	2.308%
5/5/2021	Los Angeles Capital Management LLC	18,430	$0.60M	0.0%	N/A	0.048%
4/15/2021	First Midwest Bank Trust Division	6,930	$0.23M	0.0%	N/A	0.018%
4/5/2021	Pacer Advisors Inc.	870	$29K	0.0%	N/A	0.002%
2/24/2021	Alyeska Investment Group L.P.	75,000	$4.13M	0.1%	N/A	0.196%
2/19/2021	JPMorgan Chase & Co.	5,580	$0.31M	0.0%	N/A	0.015%
2/18/2021	Verition Fund Management LLC	574,456	$31.61M	0.3%	N/A	1.501%
2/16/2021	Orbimed Advisors LLC	255,600	$14.06M	0.1%	N/A	0.668%
2/16/2021	Alyeska Investment Group L.P.	75,000	$4.13M	0.1%	N/A	0.196%
2/16/2021	Nuveen Asset Management LLC	40,614	$2.23M	0.0%	N/A	0.106%
2/16/2021	Davidson Kempner Capital Management LP	10,000	$0.55M	0.0%	N/A	0.026%
2/16/2021	Avoro Capital Advisors LLC	1,545,495	$68.71M	1.2%	N/A	4.039%
2/16/2021	Janus Henderson Group PLC	897,372	$49.37M	0.0%	N/A	2.345%
2/16/2021	Acuta Capital Partners LLC	75,645	$4.16M	1.1%	N/A	0.198%
2/16/2021	Charles Schwab Investment Management Inc.	69,760	$3.84M	0.0%	N/A	0.182%
2/13/2021	American International Group Inc.	6,411	$0.35M	0.0%	N/A	0.017%
2/13/2021	Vida Ventures Advisors LLC	2,939,329	$161.72M	33.2%	N/A	7.682%
2/12/2021	Opaleye Management Inc.	63,416	$3.49M	0.5%	N/A	0.166%
2/12/2021	Caas Capital Management LP	5,000	$0.28M	0.0%	N/A	0.013%
2/12/2021	Laurion Capital Management LP	50,000	$2.75M	0.0%	N/A	0.131%
2/12/2021	The Manufacturers Life Insurance Company	6,362	$0.35M	0.0%	N/A	0.017%
2/12/2021	Harvard Management Co. Inc.	792,617	$43.61M	2.4%	N/A	2.072%

Data available starting January 2016

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc.; a license agreement Purdue Neuroscience Company; a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Cambridge, Massachusetts.

Today's Range

Now: $20.44

$18.66

$21.26

50 Day Range

MA: $18.95

$13.15

$22.56

52 Week Range

Now: $20.44

$12.71

$60.95

Volume

123,608 shs

Average Volume

273,258 shs

Market Capitalization

$913.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Praxis Precision Medicines?: Praxis Precision Medicines' top insider investors include:
Marcio Souza (CEO)
Parallel Master Fund LP Bsof (Major Shareholder)